Traditional Chinese Medicine for the treatment of viral myocarditis and its applications

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-08000330

Enrollment

Unknown

Registered

2008-11-24

Start date

2008-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

viral myocarditis

Interventions

A:Basic treatment (rest, less excercises, diet control, 10% glucose 500 ml + 10% KCl 15 ml + insulin 8 U, inosine 400 mg, intravenous use once a day for 2 weeks) + Western durgs (Vitamin C 0.2 po. tid

B:Basic treatment (rest, less excercises, diet control, 10% glucose 500 ml + 10% KCl 15 ml + insulin 8 U, inosine 400 mg, intravenous use once a day for 2 weeks) + TCM therapy

Eligibility

Sex/Gender

All

Age

14 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Evidence of viral infection, such as influenza, acute pharyngitis, tonsillitis and diarrhea; 2. Positive anti-Coxsackievirus antibody; or decreased white blood cell and neutrophil counts with negative anti-Coxsackievirus antibody; 3. With Symptoms after the viral infections, such as palpitation, chest distress, chest pain, short of breath and fatigue; 4. ECG or dynamic ECG shows ischemic change, arrhythmia, abnormal Q wave; or ultrasonic cardiogram shows the enlargement of heart and heart failure; 5. CK-MB or cInI / cTnT > 2 times of the normal ranges; 6. The duration of the disease < 3 months; 7. Meet the criteria of syptoms differentiation of TCM; 8. Aged between 14 and 40; 9. Informed contents obtained.

Exclusion criteria

Exclusion criteria: 1. Severe complications, such as severe arrhythmia and heart failure; 2. CK-MB or cInI / cTnT > 10 times of the normal ranges; 3. With similar symptoms caused by cardiac Neurosis, beta receptor anaphylactia syndrome and dilated cardiomyopathy; 4. Combined with other severe diseases; 5. Pregnant or breast-feeding females; 6. With psychotic disorders; 7. Allergic constitution; 8. Patients that take part in other drugs trials.

Design outcomes

Primary

Measure	Time frame
Markers of myocardial injury;ECG, dynamic EC;	—

Secondary

Measure	Time frame
TCM symptoms differentiation parameter;	—

Countries

China

Contacts

Public ContactLihua Han, Zhentao Wang

hlhaa@sina.com+86 0371 60908801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026